GL1X · GenesisL1 explorer

Research workbench

Human transthyretin (ttr) in complex with 1,3-dibromo-2- hydroxy-5-phenoxybenzene

Analyse Human transthyretin (ttr) in complex with 1,3-dibromo-2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3CN3
Type
protein
Length
229 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
LJ4
Pockets
2 · best druggability 0.32

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1155% helix, 53% strandP02766
BTransthyretinprotein1146% helix, 54% strandP02766

Ligands and binding sites

  • LJ4 · 2,6-dibromo-4-phenoxyphenol · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1580.320.7613empty
2660.310.7516empty

Interfaces

1 interface between chains.

  • A–B · 919 Ų buried · 18 hydrogen bonds · protein-protein

Compared structures

  • 3CN3 · Human transthyretin (TTR) in complex with 1,3-Dibromo-2-hydroxy-5-phenoxybenzene · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.